Physician profile
Leah Yukie Nakamura
NPI 1063626893
$16,763.51
in general payments reported to CMS, 2019-2025
40 companies · $2,969 in 2025
The $2,969 reported for 2025 was more than what 77% of Urogynecology and Reconstructive Pelvic Surgery (Urology) providers received nationally (typical 2025 total: $782).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,672 · 2020: $1,330 · 2021: $1,805 · 2022: $3,561 · 2023: $2,643 · 2024: $2,785 · 2025: $2,969.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,839 · Travel and Lodging: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,839.41 |
| Travel and Lodging | $556.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,930.28 | 2021-2025 | Interstim, Altaviva |
| Axonics, INC. | $2,925.83 | 2020-2024 | Axonics |
| Caldera Medical, INC | $1,585.71 | 2021-2024 | Desara |
| Medtronic USA, INC. | $1,147.41 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $999.82 | 2023-2025 | Gemtesa |
| Coloplast Corp | $857.26 | 2019-2024 | |
| Boston Scientific Corporation | $674.58 | 2019-2025 | Advantage System, Solyx Sis System, Ams 700 |
| Bluewind Medical | $665.61 | 2024-2025 | Revi |
| Abbvie INC. | $645.86 | 2022-2025 | |
| Astellas Pharma US INC | $598.30 | 2019-2025 | Xtandi, Myrbetriq |
| Valencia Technologies Corporation | $549.94 | 2022 | |
| Allergan, INC. | $367.36 | 2019-2022 | |
| Contura, INC. | $366.54 | 2020 | |
| Pfizer INC. | $342.70 | 2021-2024 | |
| Urovant Sciences INC | $306.79 | 2021-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Femselect INC. | $228.29 | 2025 | Enplace |
| Antares Pharma, INC. | $196.14 | 2021-2025 | Xyosted, Tlando, Nocdurna |
| Calyxo, INC. | $165.78 | 2024-2025 | Cvac Aspiration System |
| Histosonics, INC. | $147.95 | 2024 | |
| Urogen Pharma, INC. | $131.20 | 2020-2025 | |
| Teleflex LLC | $123.15 | 2024 | Urolift, Solesta |
| Dornier Medtech America, INC | $104.06 | 2020 | |
| Urocure LLC | $98.69 | 2020 | |
| Palette Life Sciences, INC. | $66.18 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $61.26 | 2024-2025 | Adstiladrin |
| Tolmar, INC. | $53.12 | 2024-2025 | Eligard |
| Merck Sharp & Dohme LLC | $52.66 | 2025 | Keytruda, Keytruda Qlex |
| Davol INC. | $50.67 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $42.25 | 2025 | Bard Urinary Drainage Bag |
| Janssen Biotech, INC. | $41.10 | 2021-2025 | Erleada |
| Bioprotect Medical, INC. | $30.55 | 2024 | Bioprotect Balloon Implant System |
| Becton, Dickinson and Company | $28.45 | 2024 | Bard Urinary Drainage Bag |
| Halozyme INC | $27.00 | 2023 | |
| Dendreon Pharmaceuticals LLC | $25.77 | 2024 | Provenge |
| Accord Healthcare, INC. | $24.06 | 2024 | |
| Procept Biorobotics Corporation | $23.37 | 2023 | Aquabeam Robotic System |
| Novartis Pharmaceuticals Corporation | $22.77 | 2024 | |
| Myovant Sciences INC. | $22.01 | 2021 | |
| Coopersurgical, INC. | $18.14 | 2025 | Ally II Ups |
| Therapeuticsmd, INC. | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leah Nakamura listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.